IP Library Granted Patent US 10,781,521
Granted Patent B2
US 10,781,521 · App. 15/986,995 · Granted Sep 22, 2020

Preparation method of dual layered coatings on magnesium alloys with fluorine/polycaprolactone for biomedical applications

Inventors: Byong Taek Lee (Cheonan-si, KR); Gun Hee Lee (Cheonan-si, KR); Preeti Makkar (Cheonan-si, KR)
Assignee: SOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION
C23C30/00A61L27/047A61L27/306A61L27/34A61L27/58C23C8/42C23C28/00A61L2420/02A61L2420/08A61L2430/02C22C23/04C23C8/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,781,521
App. No.
15/986,995
Granted
Sep 22, 2020
Kind
B2
Abstract

The present invention relates to a method for preparing a dual-layer magnesium alloy with fluoride and biopolymer coatings, wherein the dual-layer MgF 2 /PCL coating exhibits improved corrosion resistance as compared to fluoride-coated samples or uncoated Mg samples, and has excellent cell viability, cell adhesion and cell proliferation. Accordingly, the magnesium alloy provided with the dual MgF 2 /PCL coating layer controls corrosion degradation of conventional orthopedic Mg alloys and exhibits excellent biocompatibility, thus being useful as an implant for fixing bones.

Claims (10)

1. A method for preparing a dual-layer coating on magnesium alloy comprising:

polishing a surface of a magnesium alloy;

treating the polished magnesium alloy with fluoride to prepare a magnesium fluoride coating layer on the magnesium alloy; and

coating the fluoride coating layer with a biopolymer solution to form a biopolymer layer.

2. The method according to claim 1 , wherein the magnesium alloy comprises zinc, zirconium and magnesium.

3. The method according to claim 1 , wherein the fluoride is hydrofluoric acid.

4. The method according to claim 1 , wherein the polymer is selected from the group consisting of polyetherimide (PEI), polycaprolactone (PCL), chitosan, polylactic acid (PLA), polyglycolic acid (PGA), a poly-ε-caprolactone-lactic acid copolymer (PCLA), a poly-ε-caprolactone-glycolic acid copolymer (PCGA), a polylactic acid-glycolic acid copolymer (PLGA), polyethylene glycol (PEG), polydioxanone (PDO), polytrimethylene carbonate (PTMC), polyamino acid, polyanhydride, polyorthoester, polyphosphazene, polyiminocarbonate, polyphosphoester, polyhydroxyvalerate, a copolymer thereof and a mixture thereof.

5. The method according to claim 1 , wherein the biopolymer solution is prepared by dissolving a biopolymer in dichloromethane.

6. The method according to claim 1 , wherein the fluoride coating layer has a thickness of 1.2 to 3.2 μm.

7. The method according to claim 1 , wherein the biopolymer coating layer has a thickness of 2.0 to 4.3 μm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2018
From: LEE, BYONG TAEK; LEE, GUN HEE; MAKKAR, PREETI
To: SOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION
Reel/Frame 046217/0635 →
Cited By (3)
US 12,446,874 US 12,458,345 US 12,539,115